Novel and nondetected human signaling protein polymorphisms

Physiological Genomics

Volumn 2002, Issue 10, 2002, Pages 159-168

  Lynch, Roy A ^a   Wagoner, Lynne ^a   Li, Shunan ^a   Sparks, Li ^a   Molkentin, Jeffery ^a   Dorn II, Gerald W ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

G protein; Heart failure

Indexed keywords

BETA ADRENERGIC RECEPTOR; DNA; GUANINE NUCLEOTIDE BINDING PROTEIN; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; PROTEIN; RAS PROTEIN; RRAD PROTEIN, HUMAN;

ARTICLE; CAUCASIAN; CHEMISTRY; CONGESTIVE HEART FAILURE; DNA SEQUENCE; FEMALE; GENETICS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MALE; METHODOLOGY; MOLECULAR GENETICS; NEGRO; NUCLEOTIDE SEQUENCE; ONCOGENE RAS; ONSET AGE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

AFRICAN CONTINENTAL ANCESTRY GROUP; AGE OF ONSET; BASE SEQUENCE; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DNA; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENES, RAS; GTP-BINDING PROTEINS; HEART FAILURE, CONGESTIVE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; MALE; MITOGEN-ACTIVATED PROTEIN KINASE 1; MOLECULAR SEQUENCE DATA; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEINS; RAS PROTEINS; RECEPTORS, ADRENERGIC, BETA; SEQUENCE ANALYSIS, DNA; SIGNAL TRANSDUCTION;

EID: 0037015189     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00030.2002     Document Type: Article

References (36)

1. Bogoyevitch MA, Gillespie-Brown J, Ketterman AJ, Fuller SJ, Ben-Levy R, Ashworth A, Marshall CJ, and Sugden PH. Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173, 1996.
2. Cambien F, Ricard S, Troesch A, Mallet C, Generenaz L, Evans A, Arveiler D, Luc G, Ruidavets JB, and Poirier O. Polymorphisms of the transforming growth factor-β1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de l'Infarctus du Myocarde (ECTIM) Study. Hypertension 28: 881-887, 1996.
3. D'Ambrosio A, Patti G, Manzoli A, Sinagra G, Di Lenarda A, Silvestri F, and Di Sciascio G. The fate of acute myocarditis between spontaneous improvement and evolution to dilated cardiomyopathy: a review. Heart 85: 499-504, 2001.
4. D'Angelo DD, Sakata Y, Lorenz JN, Boivin GP, Walsh RA, Liggett SB, and Dorn GW II. Transgenic Gαq overexpression induces cardiac contractile failure in mice. Proc Natl Acad Sci USA 94: 8121-8126, 1997.
5. Dominguez LJ, Parrinello G, Amato P, and Licata G. Trends of congestive heart failure epidemiology: contrast with clinical trial results. Cardiologia 44: 801-808, 1999.
6. Fujioka S, Kitaura Y, Ukimura A, Deguchi H, Kawamura K, Isomura T, Suma H, and Shimizu A. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol 36: 1920-1926, 2000.
7. Garcia JM, Gonzalez R, Silva JM, Dominguez G, Vegazo IS, Gamallo C, Provencio M, Espana P, and Bonilla F. Mutational status of K-ras and TP53 genes in primary sarcomas of the heart. Br J Cancer 82: 1183-1185, 2000.
8. Garg R and Yusuf S. Overview of randomized trials of angiotensin-converting enzyme inhibitors on mortality and morbidity in patients with heart failure. Collaborative Group on ACE Inhibitor Trials. JAMA 273: 1450-1456, 1995.
9. Hall RA, Premont RT, and Lefkowitz RJ. Heptahelical receptor signaling: Beyond the G protein paradigm. J Cell Biol 145: 927-932, 1999.
10. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, Evans A, Ruidavets JB, Luc G, Bara L, Parra HJ, Poirier O, and Cambien F. Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 28: 59-66, 1998.
11. Ho KK, Pinsky JL, Kannel WB, and Levy D. The epidemiology of heart failure: the Framingham Study. J Am Coll Cardiol 22: 6A-13A, 1993.
12. Hong HH, Devereux TR, Melnick RL, Moomaw CR, Boorman GA, and Sills RC. Mutations of ras protooncogenes and p53 tumor suppressor gene in cardiac hemangiosarcomas from B6C3F1 mice exposed to 1,3-butadiene for 2 years. Toxicol Pathol 28: 529-534, 2000.
13. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams CS, Charru A, Hunt SC, Hopkins PN, Williams RR, and Lalouel JM. Molecular basis of human hypertension: role of angiotensinogen. Cell 71: 169-180, 1992.
14. Karga H, Papaioannou P, Karayianni M, Papadimitriou K, Priftis D, Voujuklakis T, Migdou B, Nanas J, and Papapetrou P. Ras oncogenes and p53 tumor suppressor gene analysis in cardiac myxomas. Pathol Res Pract 196: 601-605, 2000.
15. Liggett SB, Wagoner LE, Craft LL, Hornung RW, Hoit BD, McIntosh TC, and Walsh RA. The Ile164 β2-adrenergic receptor polymorphism adversely affects the outcome of congestive heart failure. J Clin Invest 102: 1534-1539, 1998.
16. Liggett SB. Beta-adrenergic receptors in the failing heart: the good, the bad, and the unknown. J Clin Invest 107: 947-948. 2001.
17. Liggett SB. Polymorphisms of the β2-adrenergic receptor. N Engl J Med 346: 536-538, 2002.
18. Marth G, Yeh R, Minton M, Donaldson R, Li Q, Duan S, Davenport R, Miller RD, and Kwok PY. Single-nucleotide polymorphisms in the public domain: how useful are they? Nat Genet 27: 371-372. 2001.
19. Martinez O and Goud B. Rab proteins. Biochim Biophys Acta 1404: 101-112, 1998.
20. McPherson JD, Marra M, Hillier L. A physical map of the human genome. Nature 409: 934-941, 2001.
21. MERIT-HF. Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure. Lancet 353: 2001-2007, 1999.
22. Molkentin JD and Dorn GW II. Cytoplasmic signaling pathways that regulate cardiac hypertrophy. Annu Rev Physiol 63: 391-426, 2001.
23. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM, and Shusterman NH. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. US Carvedilol Heart Failure Study Group. N Engl J Med 334: 1349-1355, 1996.
24. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, and Soubrier F. An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 86: 1343-1346, 1990.
25. Rischewski J and Schneppenheim R. Screening strategies for a highly polymorphic gene: DHPLC analysis of the Fanconi anemia group A gene. J Biochem Biophys Methods 47: 53-64, 2001.
26. Schocken DD, Arrieta MI, Leaverton PE, and Ross EA. Prevalence and mortality rate of congestive heart failure in the United States. J Am Coll Cardiol 20: 301-306, 1992.
27. Simon MI, Strathmann MP, and Gautam N. Diversity of G proteins in signal transduction. Science 252: 802-808, 1991.
28. Small KM, Seman CA, Castator A, Brown KM, and Liggett SB. False positive non-synonymous polymorphisms of G-protein coupled receptor genes. FEBS Lett 516: 253-256, 2002.
29. Small KM, Rathz DA, and Liggett SB. Identification of adrenergic receptor polymorphisms. Methods Enzymol 343: 459-475, 2002.
30. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. N Engl J Med 325: 293-302, 1991.
31. Vatner DE, Yang GP, Geng YJ, Asai K, Yun JS, Wagner TE, Ishikawa Y, Bishop SP, Homcy CJ, and Vatner SF. Determinants of the cardiomyopathic phenotype in chimeric mice overexpressing cardiac Gsα. Circ Res 86: 802-806, 2000.
32. Venter JC et al. (Celera Genomics). The sequence of the human genome. Science 291: 1304-1351, 2001.
33. Wagoner LE, Craft LL, Singh B, Suresh DP, Zengel PW, McGuire N, Abraham WT, Chenier TC, Dorn GW II, and Liggett SB. Polymorphisms of the β2-adrenergic receptor determine exercise capacity in patients with heart failure. Circ Res 86: 834-840, 2000.
34. Wettschureck N, Rutten H, Zywietz A, Gehring D, Wilkie TM, Chen J, Chien KR, and Offermanns S. Absence of pressure overload induced myocardial hypertrophy after conditional inactivation of Gαq/Gα11 in cardiomyocytes. Nat Med 7: 1236-1240, 2001.
35. Wu G, Yussman MG, Barrett TJ, Hahn HS, Osinska H, Hilliard GM, Wang X, Toyokawa T, Yatani A, Lynch RA, Robbins J, and Dorn GW II. Increased myocardial Rab GT-Pase expression: a consequence and cause of cardiomyopathy. Circ Res 89: 1130-1137, 2001.
36. Yamazaki T, Tobe K, Hoh E, Maemura K, Kaida T, Komuro I, Tamemoto H, Kadowaki T, Nagai R, and Yazaki Y. Mechanical loading activates mitogen-activated protein kinase and S6 peptide kinase in cultured rat cardiac myocytes. J Biol Chem 268: 12069-12076, 1993.